Dr. Hiroyuki Uchida is an Associate Professor at the Department of Neuropsychiatry, Keio University School of Medicine in Tokyo, Japan. He specializes in clinical psychopharmacology in schizophrenia and depression.
He received his MD and PhD at Keio University School of Medicine in 1998 and 2006. Following his graduate training, he joined the Centre for Addiction and Mental Health, Toronto, and conducted brain imaging studies and pharmacokinetic work with a focus on aging in schizophrenia as a post-doctoral fellow. Dr. Uchida came back to Keio University School of Medicine and became the head of Psychopharmacology Lab.
Dr. Uchida has been performing a series of clinical trials, brain imaging work, and pharmacokinetic studies, focusing on the optimal treatment for schizophrenia and depression. He has received numerous academic awards, including the Collegium Internationale Neuro-Psychopharmacologicum, Poster Award, the American Association for Geriatric Psychiatry, Barry Lebowitz Early Career Scientist Award, and the Japanese Society of Neuropsychopharmacology, Academic Encouragement Award. He works as a co-editor for Pharmacopsychiatry, a field editor for Psychiatry and Clinical Neurosciences, an advisory editor for Psychopharmacology, and an editorial board member for CNS Spectrums.
He is a Judo black belt holder.